DVA - DaVita Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
58.56
-0.65 (-1.10%)
As of 1:21PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close59.21
Open59.14
Bid58.55 x 1400
Ask58.58 x 1000
Day's Range57.88 - 59.49
52 Week Range48.25 - 79.11
Volume754,417
Avg. Volume1,660,057
Market Cap9.744B
Beta (3Y Monthly)1.72
PE Ratio (TTM)63.65
EPS (TTM)0.92
Earnings DateMay 13, 2019 - May 17, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est67.22
Trade prices are not sourced from all markets
  • Here's Why Investors Should Hold DaVita (DVA) Stock Now
    Zacks4 hours ago

    Here's Why Investors Should Hold DaVita (DVA) Stock Now

    DaVita (DVA) steadily expands in international markets. Moreover, the company has witnessed Dialysis services in the United States lately.

  • DaVita Celebrates 12 Consecutive Years Among FORTUNE® Magazine's World's Most Admired Companies®
    PR Newswireyesterday

    DaVita Celebrates 12 Consecutive Years Among FORTUNE® Magazine's World's Most Admired Companies®

    DENVER, Feb. 21, 2019 /PRNewswire/ -- DaVita Inc. (DVA) a leading provider of kidney care services in the United States and 10 other countries, announced today that the company has been recognized as one of FORTUNE® Magazine's World's Most Admired Companies of 2019. "As a health care community, we are continuously striving to improve and will always seek new ways to best serve our patients," said Kent Thiry, chairman and CEO of DaVita. To compile its rankings, FORTUNE® surveys company executives, board members and industry analysts.

  • New Strong Sell Stocks for February 19th
    Zacks3 days ago

    New Strong Sell Stocks for February 19th

    Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today

  • Morningstar7 days ago

    Berkshire Picks Up Red Hat and Suncor, Dumps Oracle

    The firm also increased its stake in JPMorgan Chase and other financials.

  • 3 Big Stock Charts for Friday: Davita, Fastenal Company and BorgWarner
    InvestorPlace7 days ago

    3 Big Stock Charts for Friday: Davita, Fastenal Company and BorgWarner

    The bulls tried their best, but when push came to shove, they just didn't have enough fight. Spurred by just a few too many lackluster earnings reports, the S&P 500 ended yesterday's action down to the tune of 0.27%.The Coca-Cola Co (NYSE:KO) was one of those names with an alarming quarterly report. KO stock fell more than 8% on the heels of expected Q4 sales and profits, but a 2019 profit outlook that was considerably less than estimated. Centurylink (NYSE:CTL) ended the day even deeper in the red, though, sliding 13% after cutting its divided in half.There were a handful of winners, like Encana (NYSE:ECA), which advanced 2.2% in step with rising oil prices, and was up another percentage point in after-hours trading. In fact, there was more bullish volume than bearish volume on Thursday. There just wasn't enough buying interest in the right stocks to lift the market over the hump.InvestorPlace - Stock Market News, Stock Advice & Trading TipsHeaded into the weekend, the stock charts of Davita (NYSE:DVA), BorgWarner (NYSE:BWA) and Fastenal Company (NASDAQ:FAST) are of the most interest. Here's why, and what to look for. Fastenal Company (FAST)Back in October, Fastenal Company shares were in something of a freefall, After bumping into a long-standing resistance line in August, all signs pointed to a trip back to the lower edge of the trading range that has framed the volatile rally going back to 2016. * Should You Buy, Sell, Or Hold These 7 Medical Cannabis Stocks? That never happened … at least not in full. Rather than making a complete pullback, FAST stock hit a low about halfway there, and then made a triple bottom and established a new support line in December.Now we're back at the long-term ceiling, and hinting at another bearish outcome. The question is, which floor is the one that will do the job? Click to Enlarge • The trading range is framed by white dashed lines on both stock charts. We bumped into the upper one this week.• The newly developed intermediate-term floor is marked with a yellow dashed line, also on both stock charts.• The weekly chart's stochastic indicator is in overbought territory, which has also coincided with pullbacks; that's not a condition that lasts long. Davita (DVA)With nothing more than a quick glance, the 0.3% gain Davita dished out yesterday is little to cheer. Indeed, DVA has been suspiciously left out of the most of the post-December rally.A closer, second look at Thursday's action, though, sets the stage for renewed bullishness in light of the other clues that have materialized over the course of the past couple of weeks. Click to Enlarge • While Thursday's gain was ho-hum, the intraday turnaround was telling. The bears had a chance to tip it over with the early move back under key short-term moving average lines, but the bulls weren't going to give up any ground.• And those bulls are certainly strong in number. Even beyond yesterday's volume surge behind the advance, the accumulation (buying) days have seen higher and higher volume.• There may be some brewing resistance around the $58.10 area, which is marked with a dashed blue line on both stock charts. BorgWarner (BWA)Finally, it's not said often enough, but there's a lot of value in spotting a surge in volatility from a particular stock, or index. When the war between the buyers and sellers heats up, it often signals a turning point.BorgWarner shares have been particularly volatile the past few days, in all the right places. It looked like the bears were going to take control last week, but the bulls made a strong statement yesterday. They also failed to move above the one key ceiling they really needed to clear, however, so the outcome of this skirmish hangs on the balance.Either way, some something big is likely to come from the melee. Click to Enlarge • The big line in the sand is $41.50, plotted with a yellow dashed line on both stock charts. That's where BorgWarner has peaked several times since October, and it was still trouble as of yesterday.• Also noteworthy, however, is how the purple 50-day moving average line has stepped up as a technical floor.• Even before yesterday's big gain, the bullish volume was brewing, suggesting the undertow is bullish. The stumble from last week, though on above-average volume, didn't take shape with a lot of bears' support.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 9 U.S. Stocks That Are Coming to Life Again * The 7 Best Video Game Stocks to Power Up Your Portfolio! * 5 Tips to Become a Better Stock Trader Compare Brokers The post 3 Big Stock Charts for Friday: Davita, Fastenal Company and BorgWarner appeared first on InvestorPlace.

  • DaVita HealthCare Partners Inc (DVA) Q4 2018 Earnings Conference Call Transcript
    Motley Fool8 days ago

    DaVita HealthCare Partners Inc (DVA) Q4 2018 Earnings Conference Call Transcript

    DVA earnings call for the period ending December 31, 2018.

  • Stock Market News For Feb 14, 2019
    Zacks8 days ago

    Stock Market News For Feb 14, 2019

    Wall Street rally continued in Wednesday buoyed by positive developments on the trade war front.

  • DaVita (DVA) Q4 Earnings Beat and Revenues Miss Estimates
    Zacks8 days ago

    DaVita (DVA) Q4 Earnings Beat and Revenues Miss Estimates

    DaVita's (DVA) Q4 results gain from increasing dialysis services in and outside the United States.

  • Associated Press9 days ago

    DaVita HealthCare: 4Q Earnings Snapshot

    On a per-share basis, the Denver-based company said it had a loss of 90 cents. Earnings, adjusted for one-time gains and costs, were 90 cents per share. The results topped Wall Street expectations. The ...

  • DaVita HealthCare (DVA) Tops Q4 Earnings Estimates
    Zacks9 days ago

    DaVita HealthCare (DVA) Tops Q4 Earnings Estimates

    DaVita HealthCare (DVA) delivered earnings and revenue surprises of 1.12% and -5.73%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

  • DaVita Inc. 4th Quarter 2018 Results
    PR Newswire9 days ago

    DaVita Inc. 4th Quarter 2018 Results

    DENVER , Feb. 13, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced results for the quarter and year ended December 31, 2018. Fourth quarter 2018 financial highlights: Consolidated revenues ...

  • What's in the Offing for DaVita (DVA) This Earnings Season?
    Zacks10 days ago

    What's in the Offing for DaVita (DVA) This Earnings Season?

    DaVita (DVA) expects headwinds in DaVita Rx, while overseas prospects of the dialysis business look bright.

  • Markit14 days ago

    See what the IHS Markit Score report has to say about Davita Inc.

    Davita Inc NYSE:DVAView full report here! Summary * Perception of the company's creditworthiness is positive and improving * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for DVA with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting DVA. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding DVA totaled $16.15 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | PositiveThe current level displays a positive indicator with a strengthening bias over the past 1-month. DVA credit default swap spreads are decreasing and near the lowest level of the last three years, which indicates improvement in the market's perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Analysts Estimate DaVita HealthCare (DVA) to Report a Decline in Earnings: What to Look Out for
    Zacks16 days ago

    Analysts Estimate DaVita HealthCare (DVA) to Report a Decline in Earnings: What to Look Out for

    DaVita HealthCare (DVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • DaVita Inc. Schedules 4th Quarter 2018 Investor Conference Call
    PR Newswire23 days ago

    DaVita Inc. Schedules 4th Quarter 2018 Investor Conference Call

    DENVER , Jan. 30, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States and in 10 countries around the world, announced today that it will hold its ...

  • 3 Top Healthcare Stocks to Buy Right Now
    Motley Fool27 days ago

    3 Top Healthcare Stocks to Buy Right Now

    Healthcare is hot. These three stocks could be among the hottest in the sector.

  • Should You Investigate DaVita Inc. (NYSE:DVA) At US$56.39?
    Simply Wall St.28 days ago

    Should You Investigate DaVita Inc. (NYSE:DVA) At US$56.39?

    DaVita Inc. (NYSE:DVA), which is in the healthcare business, and is based in United States, saw a double-digit share price rise of over 10% in the past couple of months Read More...

  • Denver-based direct primary-care provider more than doubling in size after acquisition
    American City Business Journals29 days ago

    Denver-based direct primary-care provider more than doubling in size after acquisition

    In its first major move since raising $165 million last summer, Denver-based Paladina Health has acquired a similar direct primary-care company that’s going to more than double its footprint and employee headcount. Paladina Health, which operates a network of clinics outside of the health insurance sphere, acquired Indianapolis-based Activate Healthcare. Chris Miller, Paladina’s chief executive officer, told Denver Business Journal that both companies will maintain their brands for now, but that could change down the road.

  • GlobeNewswirelast month

    Recent Analysis Shows Abercrombie & Fitch, DaVita, W.W. Grainger, Ingredion, FirstEnergy, and Second Sight Medical Products Market Influences — Renewed Outlook, Key Drivers of Growth

    NEW YORK, Jan. 22, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • Baxter (BAX) Gains From Sharesource's Global Success Rates
    Zackslast month

    Baxter (BAX) Gains From Sharesource's Global Success Rates

    Baxter's (BAX) PD platform sees increased demand, owing to rising CKD rates around the world.

  • New Technology Helps Nephrologists Better Manage Patients with Chronic Kidney Disease
    PR Newswirelast month

    New Technology Helps Nephrologists Better Manage Patients with Chronic Kidney Disease

    DaVita Physician Solutions rolls out CKD EHR by Epic nationwide DENVER , Jan. 17, 2019 /PRNewswire/ --   DaVita Physician Solutions , a wholly owned subsidiary of DaVita Inc. (NYSE:DVA), today announced ...

  • CNBClast month

    Dow component UnitedHealth pops 1% on earnings beat

    UnitedHealth UNH shares jumped 1 percent in premarket trading Tuesday after it reported fourth-quarter earnings that beat Wall Street's expectations, helped by growth in its services business. Revenue from Optum, which includes the company's pharmacy benefits management business, grew 13 percent to $27.56 billion in the fourth quarter, while revenue from its mainstay insurance business grew 11.1 percent to $46.23 billion. UnitedHealth reaffirmed its 2019 forecast for earnings between $14.40 and $14.70 per share.